Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomePreferred Shares IssuedSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

DarioHealth (DRIO) Shares Repurchased (2014 - 2016)

DarioHealth posted quarterly Shares Repurchased of $2.3 million for Q1 2016, up 2132.35% year-on-year from $102000.0 in Q2 2015, and up 227800.0% on a QoQ basis from -$1000.0 in Q3 2015.

DarioHealth (DRIO) has 3 years of Shares Repurchased data on file, last reported at $2.3 million in Q1 2016.

  • For the quarter ending Q1 2016, Shares Repurchased rose 2132.35% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2016 stood at $2.3 million (up 469.25% YoY), and the FY2022 full-year result was $134000.0, changed N/A from the prior year.
  • Shares Repurchased for Q1 2016 stood at $2.3 million, up from -$1000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.3 million in Q1 2016 and bottomed at -$9000.0 in Q3 2014.
  • The 3-year median for Shares Repurchased is $46000.0 (2014), against an average of $389000.0.
  • Peak annual rise in Shares Repurchased reached 3222.22% in 2015, while the deepest fall reached 88.89% in 2015.
  • A 3-year view of Shares Repurchased shows it stood at $46000.0 in 2014, then tumbled by 102.17% to -$1000.0 in 2015, then surged by 227800.0% to $2.3 million in 2016.
  • The last three Shares Repurchased figures came in at $2.3 million (Q1 2016), -$1000.0 (Q3 2015), and $299000.0 (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 60.00 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 123.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 104.97 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 90.53 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 DarioHealth 50.62 Mn 50.62 Mn 3.20 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2016 2.28 Mn
Mar 31, 2016 2.28 Mn
Sep 30, 2015 -1,000.00
Sep 30, 2015 -1,000.00
Jun 30, 2015 299,000.00
Jun 30, 2015 299,000.00
Mar 31, 2015 102,000.00
Mar 31, 2015 102,000.00
Dec 31, 2014 46,000.00
Dec 31, 2014 46,000.00
Sep 30, 2014 -9,000.00
Sep 30, 2014 -9,000.00
Jun 30, 2014 9,000.00
Jun 30, 2014 9,000.00